Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 2 min ago
Peer-reviewedCC BY 4.0Emerging Infectious Diseases

Subacute Sclerosing Panencephalitis after Measles Outbreaks, the Philippines, 2007–2022

Abstract

Subacute sclerosing panencephalitis (SSPE) is a delayed, almost uniformly fatal complication of measles. The Philippines had measles outbreaks in 2010–2011, 2013, and 2018–2019; the last was the largest in the World Health Organization Western Pacific Region. Published SSPE data from the Philippines end in 2015. We reviewed all 20 children admitted with SSPE to a tertiary pediatric hospital in Quezon City during 2007–2022 and estimated year of measles infection. Median patient age was 6.2 years at hospital admission and 0.7 years at reported measles illness. Five (25.0%) of 20 admissions occurred in 2022, and estimated infection dates placed 4 patients within the 2018–2019 outbreak; all were admitted during 2020–2022. Given the multiyear latency of SSPE, additional cases might emerge over coming years. Reported measles history could not be established in one quarter of patients. Strengthened measles surveillance and sustained 2-dose vaccination coverage are needed.

Related

  1. Comparative analysis of central nervous system persistence of morbilliviruses across host species reveals shared features with subacute sclerosing panencephalitis
    Rik L. de Swart, Rory D. de Vries
    One Health OutlookPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
  2. Five critical blind spots limiting translational progress in primary sclerosing cholangitis.
    Martin Cornillet
    Hepatology communicationsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Complex sclerosing lesions of the breast mimicking carcinoma: diagnostic pitfalls and the decisive role of immunohistochemistry
    Shuo Zhang, Jiaxing Wang, Lei Han +1
    Annals of medicine and surgery (2012)Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Pulmonary sclerosing pneumocytoma demonstrated heterogeneous tumor growth rate on serial CT: a retrospective cohort study
    Xiaoyu Zhen, Li Tu, Hong Xie +5
    Journal of thoracic diseasePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Sclerosing epithelioid fibrosarcoma of the bone: a systematic review of radiologic findings and associated clinical features
    Fatemeh Kanaani Nejad, Maryam Afshari, Alireza Keshtkar +3
    Annals of medicine and surgery (2012)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{palisoc2026subacute,
  title = {{Subacute Sclerosing Panencephalitis after Measles Outbreaks, the Philippines, 2007–2022}},
  author = {Maela P. Palisoc and Maridel S. Ramones and Roland Dominic G. Jamora},
  journal = {Emerging Infectious Diseases},
  year = {2026},
  month = oct,
  doi = {10.3201/eid3211.261395},
  url = {https://doi.org/10.3201/eid3211.261395},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Subacute Sclerosing Panencephalitis after Measles Outbreaks, the Philippines, 2007–2022
AU  - Maela P. Palisoc
AU  - Maridel S. Ramones
AU  - Roland Dominic G. Jamora
PY  - 2026
DA  - 2026/10/30
JO  - Emerging Infectious Diseases
DO  - 10.3201/eid3211.261395
UR  - https://doi.org/10.3201/eid3211.261395
AB  - Subacute sclerosing panencephalitis (SSPE) is a delayed, almost uniformly fatal complication of measles. The Philippines had measles outbreaks in 2010–2011, 2013, and 2018–2019; the last was the largest in the World Health Organization Western Pacific Region. Published SSPE data from the Philippines end in 2015. We reviewed all 20 children admitted with SSPE to a tertiary pediatric hospital in Quezon City during 2007–2022 and estimated year of measles infection. Median patient age was 6.2 years at hospital admission and 0.7 years at reported measles illness. Five (25.0%) of 20 admissions occurred in 2022, and estimated infection dates placed 4 patients within the 2018–2019 outbreak; all were admitted during 2020–2022. Given the multiyear latency of SSPE, additional cases might emerge over coming years. Reported measles history could not be established in one quarter of patients. Strengthened measles surveillance and sustained 2-dose vaccination coverage are needed.
SN  - 1080-6040
SN  - 1080-6059
ER  -